6 completed. 4 Phase 1, 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow AZD8529: new trials by email Literature Review of AZD8529 trials Research Report on AZD8529
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Study of AZD8529 for Smoking Cessation in Female Smokers AZD8529 - Tobacco Use Disorder | Phase 2 | Completed | National Institute on Drug Abuse (NIDA) | 214 | 2015-07-01 | 2017-11-29 |
| The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy Volunteers AZD8529, Placebo to match AZD8529 - Healthy, Memory Impairment | Early Phase 1 | Completed | AstraZeneca | 20 | 2010-02-01 | 2011-05-04 |
| The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics AZD8529, Placebo to match AZD8529 - Schizophrenia | Phase 1 | Completed | AstraZeneca | 59 | 2009-11-01 | 2011-11-01 |
| AZD8529 Single Ascending Dose Study in Healthy Japanese Subjects AZD8529, Placebo - Healthy | Phase 1 | Completed | AstraZeneca | 48 | 2009-04-01 | 2009-08-19 |
| AZD8529 Multiple Ascending Dose Study in Healthy Subjects AZD8529, Placebo - Healthy Volunteer | Phase 1 | Completed | AstraZeneca | 47 | 2008-10-01 | 2009-06-26 |
| AZD8529 Single Ascending Dose Study AZD8529, Placebo - Healthy Volunteer | Phase 1 | Completed | AstraZeneca | 58 | 2008-09-01 | 2009-03-26 |
Memory Disorders (1) · Schizophrenia (1) · Smoking (1) · Smoking Cessation (1) · Tobacco Use Disorder (1)
AstraZeneca (5) · National Institute on Drug Abuse (NIDA) (1)
United States (4) · United Kingdom (1)
John Krystal (1) · Mark Smith, MD, PhD (1) · Raquel Gur (1) · Shwe Gyaw, MD (1) · Sylvan J Hurewitz, MD (1) · Ulrike Lorch, MD MFPM FRCA (1)
2009 (1)